Phenylamide and pyridylamide betasecretase inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2004311749 (hide)

Owner Merck & Co., Inc.

Inventors Zhuang, Linghang; Stauffer, Shaun R.; Coburn, Craig A.; Stanton, Matthew G.; Selnick, Harold G.; Barrow, James C.; Davis, Jennifer R.; Nantermet, Philippe G.; Stachel, Shawn J.

Agent Spruson & Ferguson

Pub. Number AU-A-2004311749

PCT Pub. Number WO2005/065195

Priority 60/531,423 19.12.03 US

Filing date 15 December 2004

Wipo publication date 21 July 2005

International Classifications

A61K 31/00 (2006.01)

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/065195 Priority application(s): WO2005/065195

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004311755-Devices and methods for controlling and indicating the length of an interven- tional element

2004311747-Fluid infusion apparatus with an insulated patient line tubing for preventing heat loss